Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma 11Lymphoma, Non-Hodgkin 9Lymphoma, Large B-Cell, Diffuse 9Burkitt Lymphoma 9Myelodysplastic Syndromes 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Acute 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Blast Crisis 6Recurrence 5Neoplasms, Plasma Cell 5Leukemia, Myeloid, Accelerated Phase 5Graft vs Host Disease 5Dendritic Cell Sarcoma, Interdigitating 5Congenital Abnormalities 5Myeloproliferative Disorders 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Juvenile 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, B-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Hematologic Neoplasms 3

Interventions

Paclitaxel 96Carboplatin 81Bevacizumab 62Gemcitabine 36liposomal doxorubicin 32pembrolizumab 30Topotecan 26olaparib 23Taxes 23niraparib 17Immunoglobulin G 17Disulfides 17Docetaxel 16Cyclophosphamide 16Cisplatin 14Nivolumab 11rucaparib 10durvalumab 10Doxorubicin 9Albumin-Bound Paclitaxel 8sargramostim 7pazopanib 7fludarabine phosphate 7fludarabine 7avelumab 7Magnetic Resonance Spectroscopy 7Ifosfamide 7epacadostat 6Trabectedin 6Sorafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ovarian Neoplasms × Methylprednisolone × Clear all
NCT01105650 2017-12-28

MT2009-30

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
13 enrolled 11 charts
BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡